| Long-term contraceptives. | |
| | |
MedLine Citation:
|
PMID: 20558111 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
To avoid unintended pregnancy, women in the UK need to consistently use reliable contraception for over 30 years. The long-acting reversible contraceptive methods compromise the progestogen-only implant, the progestogen-only injectable contraceptive, the copper-bearing intra-uterine device and the levonorgestrel-releasing intra-uterine system. These methods of contraception are highly reliable in pregnancy prevention, and are amongst the medically safest methods for users. Despite this, these long-acting methods are used by less than 10% of the UK population. National guidance has advised that increasing uptake of these long-acting methods will reduce the unplanned pregnancy rate. In addition, these methods are more cost effective than the oral contraceptive even at 1 year of use. Obstetricians and gynaecologists frequently come into contact with women requiring contraceptive advice, and should have a sound knowledge of the long-acting methods. |
| | |
Authors:
|
Audrey Brown |
Publication Detail:
|
Type: Journal Article Date: 2010-06-16 |
Journal Detail:
|
Title: Best practice & research. Clinical obstetrics & gynaecology Volume: 24 ISSN: 1532-1932 ISO Abbreviation: Best Pract Res Clin Obstet Gynaecol Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: 2011-01-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101121582 Medline TA: Best Pract Res Clin Obstet Gynaecol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 617-31 Citation Subset: IM |
Copyright Information:
|
Copyright 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Sexual and Reproductive Healthcare, 2-6 Sandyford Place, Glasgow, Scotland G3 7NB, UK. audreybrown@nhs.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Cutaneous Adolescent Adult Contraception / methods* Contraceptive Agents, Female / administration & dosage*, adverse effects*, contraindications Drug Implants / adverse effects, contraindications Female Humans Injections, Subcutaneous Intrauterine Devices, Copper / adverse effects, contraindications Intrauterine Devices, Medicated / adverse effects, contraindications Middle Aged Pregnancy Progestins / administration & dosage*, adverse effects, contraindications Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Contraceptive Agents, Female; 0/Drug Implants; 0/Progestins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Minor diurnal and activity-induced variations in daytime peripheral blood platelet counts do not hav...
Next Document: Newly diagnosed epilepsy: cognitive outcome at 5 years.